Printer Friendly

SIX STUDENTS SELECTED AS PHARMACEUTICAL INDUSTRY INTERNS AT BRISTOL-MYERS SQUIBB COMPANY

 PRINCETON, N.J., May 6 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) has named six pharmacy students who will participate in its 1993 Pharmaceutical Industry Summer Internship Program from May 24 through Aug. 6, 1993.
 The program was established in 1973 through the National Pharmaceutical Council (NPC) and the American Pharmaceutical Association's Academy of Students of Pharmacy (APhA/ASP).
 The six students, who were chosen from hundreds of applicants nationwide, are:
 Aleesha Boon, a fifth-year pharmacy student at the University of Colorado School of Pharmacy;
 Maribeth Brune, a fifth-year pharmacy student at the University of South Carolina School of Pharmacy;
 Scott E. Kaufman, a fifth-year doctor of pharmacy student at the University of Arkansas for Medical Sciences;
 Elleni J. Pippis, a fifth-year pharmacy student at the Philadelphia College of Pharmacy and Sciences;
 Lucia M. Riva, a sixth-year doctor of pharmacy student at the University of Southern California; and
 Joseph F. Tooley, a sixth-year doctor of pharmacy student at the University of Nebraska Medical Center.
 "The NPC summer interns sponsored by our company over the years have said the experience gave them an industry background not available in a classroom," said Sam L. Barker, Ph.D., president, Bristol-Myers Squibb U.S. Pharmaceutical Division. "Bristol-Myers Squibb Company is happy to provide the opportunity for pharmacy students to learn through practical experience and first-hand observation in a structured program with careful supervision."
 The 1993 interns will be assigned to product teams at the company's newest complex in Plainsboro, N.J. Boon and Pippis will work in the area of anti-infectives, Brune and Riva will work in the area of cardiovasculars, Tooley in the metabolic area, and Kaufman in the area of central nervous system pharmaceuticals.
 "The interns will be based in the Medical Operations Department of the U.S. Pharmaceutical Division and will work with various other functions within the Division," said Joseph Grzymkowski, director, Trade Relations, Bristol-Myers Squibb U.S. Pharmaceutical Operations, who coordinates the program for the company. "They also will attend seminars led by company department heads, and will complete special assignments within their product groups." Serving as preceptor for the program is David Domann, assistant director, Bristol-Myers Squibb Professional Services.
 The NPC internship program is designed to broaden and improve pharmacy students' overall knowledge of the pharmaceutical industry and its essential role in the areas of pharmacy and healthcare. This is the 21st year that Bristol-Myers Squibb Company has served as a sponsor.
 Bristol-Myers Squibb Company is a research-based, diversified healthcare company whose principal businesses are pharmaceuticals, consumer products, nutritionals and medical devices. It is among the world's leading makers of cardiovascular, anticancer, anti-infective, central nervous system and dermatological drug therapies, diagnostic agents and non-prescription medications.
 /delval/
 -0- 5/6/93
 /CONTACT: Patrick D. Donohue of Bristol-Myers Squibb, 609-252-5685, or Kathy Loehrig or Linda Pollock of Anne Klein & Associates, 609-778-0380, of Bristol-Myers Squibb/
 (BMY)


CO: Bristol-Myers Squibb ST: New Jersey IN: MTC SU: PER

MP -- PH004 -- 5250 05/06/93 09:05 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 6, 1993
Words:493
Previous Article:WESTBRIDGE CAPITAL REPORTS NET OPERATING PROFIT UP 172 PERCENT FOR THE 1993 FIRST QUARTER
Next Article:ISROFF HONORED AS TOP HOSPITAL TRUSTEE
Topics:


Related Articles
BRISTOL-MYERS SQUIBB EXECUTIVE JOAN K. KEITH TO BE HONORED APRIL 7 AS HEALTHCARE BUSINESSWOMEN'S ASSOCIATION WOMAN OF THE YEAR
BRISTOL-MYERS SQUIBB PROMOTES WEG TO GROUP PRESIDENT
BRISTOL-MYERS SQUIBB COMPANY PROMOTES SPECIALTY PHARMACEUTICALS EXECUTIVE
BRISTOL-MYERS SQUIBB PHARMACEUTICAL
DR. SHARON HENRY OF BRISTOL-MYERS SQUIBB COMPANY RECEIVES HEALTH WATCH'S FIRST WOMEN'S LEADERSHIP AWARD
BRISTOL-MYERS SQUIBB COMPANY PROMOTES LEGAL EXECUTIVE
BRISTOL-MYERS SQUIBB COMPANY CREATESINNOVATIVE SALES CONSULTANT PROGRAM
MINORITY MEDICAL FELLOWS PRESENT RESEARCH AT ANNUAL SYMPOSIUM; BRISTOL-MYERS SQUIBB COMPANY PROVIDES 35 FELLOWSHIP GRANTS
DR. SOL I. RAJFER APPOINTED TO BRISTOL-MYERS SQUIBB SR. VICE PRESIDENT WORLDWIDE CLINICAL R&D
First Annual Bristol-Myers Squibb Symposium to Further Interest in Synthetic Organic Chemistry; Unrestricted Grant Recipients and Fellows to Present...

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters